Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2923-2931

  Weidt, Gunnar ^a,b   Utermöhlen, Olaf ^a   Heukeshoven, Jochen ^a   Lehmann Grube, Fritz ^a   Deppert, Wolfgang ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS MENINGITIS;

ANIMALS; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 2642704191     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Falk, K., O. Rötzschke, and H.-G. Rammensee. 1992. Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man. Eur. J. Immunol. 22:1323.
2. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
3. Rötzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
4. Schumacher, T. N. M., D. V. Kantesaria, M.-T. Heemels, P. G. Ashton-Rickardt, J. C. Shepherd, K. Fruh, Y. Yang, P. A. Peterson, S. Tonegawa, and H. L. Ploegh. 1994. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179:533.
5. Sijts, A., A. Neisig, J. Neefjes, and E. G. Pamer. 1996. a. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156:685.
6. Sijts, A. J., M. S. Villanueva, and E. G. Pamer. 1996. b. CTL epitope generation is tightly linked to cellular proteolysis of a Listeria monocytogenes antigen. J. Immunol. 156:1497.
7. Eberl, G., B. Kessler, L. P. Eberl, M. J. Brunda, D. Valmori, and G. Corradin. 1996. Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. Eur. J. Immunol. 26:2709.
8. Daly, K., P. Nguyen, D. L. Woodland, and M. A. Blackman. 1995. Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J. Virol. 69:7416.
9. Perkins, D. L., Y. S. Wang, D. Fruman, J. G. Seidman, and I. J. Rimm. 1991. Immunodominance is altered in T cell receptor (β-chain) transgenic mice without the generation of a hole in the repertoire. J. Immunol. 146:2960.
10. b-restricted epitopes. J. Immunol. 157:5555.
11. von Herrath, M. G., J. Dockter, M. Nerenberg, J. E. Gairin, and M. B. A. Oldstone. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901.
12. Mylin, L. M., R. H. Bonneau, J. D. Lippolis, and S. S. Tevethia. 1995. a. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
13. b-restricted determinant in simian virus 40 tumor antigen. Virology 208:159.
14. b cytotoxic T lymphocytes. J. Exp. Med. 168:559.
15. d. Transplant. Proc. 4:2024.
16. d gene acts as a restriction element for LCMV-specific killer T cells. Nature 297:415.
17. Gegin, C., and F. Lehmann-Grube. 1992. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 149:3331.
18. d gene. Proc. Natl. Acad. Sci. USA 83:9606.
19. Weidt, G., W. Deppert, O. Utermöhlen, J. Heukeshoven, and F. Lehmann-Grube. 1995. b. Emergence of virus escape mutants after immunization with epitope vaccine. J. Virol. 69:7147.
20. Rivers, T. M., and T. F. M. Scott. 1935. Meningitis in man caused by a filterable virus. Science 81:439.
21. Lehmann-Grube, F., and J. Ambrassat. 1977. A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera. J. Gen. Virol. 37: 85.
22. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D. H. L. Bishop, H. Overton, and R. M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCM-WE nucleoprotein or glycoprotein. J. Immunol. 19:417.
23. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H. Hengartner, and R. M. Zinkernagel. 1989. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657.
24. Atherton, E., and R. C. Sheppard. 1989. Solid Phase Peptide Synthesis: A Practical Approach. IRL Press, Oxford.
25. Berthold, H., M. Scanarini, C. C. Abney, B. Frorath, and W. Northemann. 1992. Purification of recombinant antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen using the expression system pH6EX3 followed by metal chelating affinity chromatography. Protein Expr. Purif. 3:50.
26. Weidt, G., W. Deppert, S. Buchhop, H. Dralle, and F. Lehmann-Grube. 1995. a. Antiviral protective immunity induced by major histocompatibility class I molecule-restricted T lymphocyte epitopes inserted in various positions in immunologically "self" and "nonself" proteins. J. Virol. 69:2654.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
28. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181.
29. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 153:2554.
30. Schirmbeck, R., W. Böhm, and J. Reimann. 1994. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur. J. Immunol. 24:2068.
31. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723.
32. Lehmann-Grube, F., J. Cihak, M. Varho, and R. Tijerina. 1982. The immune response of the mouse to lymphocytic choriomeningitis virus. II. Active suppression of cell-mediated immunity by infection with high virus doses. J. Gen. Virol. 58:223.
33. Oldstone, M., H. Lewicki, P. Borrow, D. Hudrisier, and J. E. Gairin. 1995. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J. Virol. 69:7423.
34. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. A. Oldstone. 1990. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393.
35. Cohen, J. 1995. High turnover of HIV in blood revealed by new studies. Science 267:179.
36. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koeppe, K. Sigmund, C. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
37. Rehermann, B., C. Pasquinelli, S. M. Mosier, and F. V. Chisari. 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96:1527.
38. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
39. Steven, N. M., A. M. Leese, N. E. Annels, S. P. Lee, and A. B. Rickinson. 1996. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J. Exp. Med. 184:1801.
40. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507.
41. Oukka, M., J. C. Manuguerra, N. Livaditis, S. Tourdot, N. Riche, I. Vergnon, P. Cordopatis, and K. Kosmatopoulos. 1996. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3019.
42. Oukka, M., N. Riche, and K. Kosmatopoulos. 1994. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells. J. Immunol. 152:4843.
43. van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. L. Lau, S. Southwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543.
44. Taracha, E. L., B. M. Goddeeris, A. J. Teale, S. J. Kemp, and W. I. Morrison. 1995. Parasite strain specificity of bovine cytotoxic T cell responses to Theileria parva is determined primarily by immunodominance. J. Immunol. 155:4854.
45. Dick, T. P., T. Ruppert, M. Groettrup, P. M. Kloetzel, L. Kuehn, U. H. Koszinowski, S. Stevanovic, H. Schild, and H. G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
46. Eggers, M., B. Boes-Fabian, T. Ruppert, P. M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865.
47. Lewicki, H. A., M. G. Von Herrath, C. F. Evans, J. L. Whitton, and M. Oldstone. 1995. b. CTL escape viral variants. II. Biologic activity in vivo. Virology 211: 443.
48. Lewicki, H., A. Tishon, P. Borrow, C. F. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell, I. A. Wilson, and M. B. A. Oldstone. 1995. a. CTL escape viral variants. I. Generation and molecular characterization. Virology 210:29.
49. Aebischer, T., D. Moskophidis, U. H. Rohrer, R. M. Zinkernagel, and H. Hengartner. 1991. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 88: 11047.
50. Moskophidis, D., and R. M. Zinkernagel. 1995. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69:2187.
51. Nowak, M. A., and C. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74.
52. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117.
53. Allan, J. E., and P. C. Doherty. 1985. Consequences of a single Ir-gene detect for the pathogenesis of lymphocytic choriomeningitis. Immungenetics 21:581.
54. Domingo, E., and J. J. Holland. 1994. Mutation Rates and Rapid Evolution. Raven Press, New York.